is semaglutide bad for liver targets MASH molecular pathways beyond weight loss Wegovy (semaglutide) for fatty liver

It also found evidence that the drug may reduce risk of cardiovascular disease, which is higher among people with HIV, by reducing liver fat

This may include stopping Ozempic

The debate is on whether this applies to humans , as rodents and humans are very different, including their thyroid function

Final Takeaway Whether GLP-1 medication is used or not, long-term metabolic health depends on one foundation : A resilient microbiome healthy SCFAs stable GLP-1 lasting metabolic balance

If you have suffered from diabetic retinopathy or kidney problems, make this known as the condition could worsen with the drug

WellSyncs white-labeled technology platform offers a seamless way to launch and manage a GLP-1 prescription program tailored to your brand and patient needs